Latest updates for Tgtx

Fresh curated links around TGTX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Is TG Therapeutics, Inc. (TGTX) A Good Stock To Buy Now?
  • TG Therapeutics, Inc. (TGTX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
  • TG Therapeutics rises on early-stage trial data for Briumvi injectable

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

finance.yahoo.com /3 weeks ago

Is TG Therapeutics, Inc. (TGTX) A Good Stock To Buy Now?

Read source
seekingalpha.com /1 month ago

TG Therapeutics, Inc. (TGTX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Read source
seekingalpha.com /1 month ago

TG Therapeutics rises on early-stage trial data for Briumvi injectable

Read source
seekingalpha.com /1 month ago

MeiraGTx Holdings plc (MGTX) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow

Read source
seekingalpha.com /1 month ago

Travere Therapeutics, Inc. (TVTX) Discusses Exclusive Licensing and Collaboration Agreement for Seborbrutinib with Evere...

Read source
seekingalpha.com /1 month ago

Tango Therapeutics, Inc. (TNGX) Discusses Promising Clinical Results for Vopimetostat and Pan-RAS Inhibitor Combination...

Read source
seekingalpha.com /1 month ago

Tango Therapeutics: 'Hold' On Combination Strategy Shift Of Vopimetostat

Read source
seekingalpha.com /1 month ago

Tango Therapeutics, Inc. (TNGX) Discusses Promising Clinical Results for Vopimetostat and Pan-RAS Inhibitor Combination...

Read source
seekingalpha.com /1 week ago

Travere Therapeutics: Filspari Is Becoming A Rare Kidney Disease Platform

Read source
seekingalpha.com /2 weeks ago

Telix Pharmaceuticals Limited (TLX) Discusses Neurologic Oncology Portfolio and Advances in Therapeutic and Diagnostic A...

Read source
finance.yahoo.com /1 month ago

Is Travere Therapeutics, Inc. (TVTX) A Good Stock To Buy Now?

Read source
seekingalpha.com /1 month ago

Cullinan Therapeutics, Inc. (CGEM) Discusses Promising Clinical Data for CLN-978 and Velinotamig in Autoimmune Diseases...

Read source
seekingalpha.com /1 month ago

Gilead: 'Hold' On Biktarvy Sales Growth And MM Drug Development Program

Read source
seekingalpha.com /5 days ago

Tryg A/S (TGVSY) Q2 2026 Earnings Call Transcript

Read source
cafepharma.com /1 month ago

Argenx

Argenx Anonymous (not verified) Sun, 06/07/2026 - 17:48 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...

Read source
cafepharma.com /1 month ago

Argenx

Argenx Anonymous (not verified) Sat, 05/30/2026 - 14:41 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...

Read source
seekingalpha.com /1 month ago

Foghorn Therapeutics Inc. (FHTX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Read source
healio.com /2 weeks ago

FDA approves Tryngolza to reduce acute pancreatitis risk

The FDA has approved olezarsen as the first and only therapy, alongside diet, to lower triglycerides and acute pancreatitis risk in patients with severe hypertriglyceridemia, accor...

Read source
fool.com /3 days ago

What This MeiraGTx Insider Sale Might Mean With Two Drug Filings Near

Stuart Naylor's 4% portfolio reduction follows an 89% one-year stock surge, executed under a pre-scheduled Rule 10b5-1 trading plan adopted in December 2025.

Read source
fool.com /1 month ago

Tango Therapeutics Stock Is Up 840%, and This Fund Just Disclosed Buying $164 Million More

This biotechnology firm advances targeted cancer therapies, leveraging genetic insights and strategic partnerships in oncology.

Read source
seekingalpha.com /1 month ago

GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment Transcript

Read source
seekingalpha.com /1 month ago

Nurix Therapeutics, Inc. (NRIX) Discusses Strategic Collaboration for Development and Commercialization of Bexobrutideg...

Read source
pharmexec.com /1 month ago

<![CDATA[Inside the Expert Network Guiding TGN-S15 to Market]]>

Read source
seekingalpha.com /1 month ago

ABIVAX Société Anonyme (ABVX) Discusses Positive Phase III ABTECT Trial Results for Obefazimod in Ulcerative Colitis - S...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Tgtx

seekingalpha.com

Recent coverage from public sources
Public source

cafepharma.com

Recent coverage from public sources
Public source

finance.yahoo.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

fool.com

Recent coverage from public sources
Public source